Atlas Trials

Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma

Clinical trial NCT05626985 · UNKNOWN

Trial details

NCT number
NCT05626985
Sponsor
Singlera Genomics Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2022-10-19
Primary completion
2024-10-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.